Mass spectrometry-based proteomics as an emerging tool in clinical laboratories

被引：0
作者：
Alemayehu Godana Birhanu
机构：
[1] Addis Ababa University,Institute of Biotechnology
来源：
Clinical Proteomics | 2023年 / 20卷
关键词：
Mass spectrometry; Clinical proteomics; Diagnosis; Biomarker; Prognosis; Microbiology; Cancer; Metabolic Disorders;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Mass spectrometry (MS)-based proteomics have been increasingly implemented in various disciplines of laboratory medicine to identify and quantify biomolecules in a variety of biological specimens. MS-based proteomics is continuously expanding and widely applied in biomarker discovery for early detection, prognosis and markers for treatment response prediction and monitoring. Furthermore, making these advanced tests more accessible and affordable will have the greatest healthcare benefit.
引用
收藏
相关论文
共 385 条
  • [11] Oliveira BM(2011)The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science Korean J Lab Med 31 61-48
  • [12] Mischak H(2015)Proteomics in cancer research: are we ready for clinical practice? Crit Rev Oncol/Hematol 96 437-9
  • [13] Mischak H(2009)Mass spectrometry-based clinical proteomics profiling: current status and future directions Expert Rev Proteomics 6 457-26
  • [14] Baker ES(2021)Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade Expert Rev Proteomics 18 503-58
  • [15] Boja ES(2014)Mass spectrometry based biomarker discovery, verification, and validation–quality assurance and control of protein biomarker assays Mol Oncol 8 840-9
  • [16] Rodriguez H(2002)Proteomics for cancer biomarker discovery Clin Chem 48 1160-84
  • [17] Maes E(2016)CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis Lancet Neurol 15 673-88
  • [18] Findeisen P(2012)Breast cancer and protein biomarkers World J experimental Med 2 86-31
  • [19] Neumaier M(2018)Proteomics applications in health: biomarker and drug discovery and food industry Iran J Pharm research: IJPR 17 1523-8
  • [20] Lill JR(2012)Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer J Proteome Res 11 1078-18
12345678910